APA

Strong R., Miller R. A., Antebi A., Astle C. M., Bogue M., Denzel M. S., Fernandez E., Flurkey K., Hamilton K. L., Lamming D. W., Javors M. A., de Magalhães J. P., Martinez P. A., McCord J. M., Miller B. F., Müller M., Nelson J. F., Ndukum J., Rainger G. E., Richardson A., Sabatini D. M., Salmon A. B., Simpkins J. W., Steegenga W. T., Nadon N. L. & Harrison D. E. (20170605). Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer. : Aging cell.

Chicago

Strong Randy, Miller Richard A, Antebi Adam, Astle Clinton M, Bogue Molly, Denzel Martin S, Fernandez Elizabeth, Flurkey Kevin, Hamilton Karyn L, Lamming Dudley W, Javors Martin A, de Magalhães João Pedro, Martinez Paul Anthony, McCord Joe M, Miller Benjamin F, Müller Michael, Nelson James F, Ndukum Juliet, Rainger G Ed, Richardson Arlan, Sabatini David M, Salmon Adam B, Simpkins James W, Steegenga Wilma T, Nadon Nancy L and Harrison David E. 20170605. Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer. : Aging cell.

Harvard

Strong R., Miller R. A., Antebi A., Astle C. M., Bogue M., Denzel M. S., Fernandez E., Flurkey K., Hamilton K. L., Lamming D. W., Javors M. A., de Magalhães J. P., Martinez P. A., McCord J. M., Miller B. F., Müller M., Nelson J. F., Ndukum J., Rainger G. E., Richardson A., Sabatini D. M., Salmon A. B., Simpkins J. W., Steegenga W. T., Nadon N. L. and Harrison D. E. (20170605). Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer. : Aging cell.

MLA

Strong Randy, Miller Richard A, Antebi Adam, Astle Clinton M, Bogue Molly, Denzel Martin S, Fernandez Elizabeth, Flurkey Kevin, Hamilton Karyn L, Lamming Dudley W, Javors Martin A, de Magalhães João Pedro, Martinez Paul Anthony, McCord Joe M, Miller Benjamin F, Müller Michael, Nelson James F, Ndukum Juliet, Rainger G Ed, Richardson Arlan, Sabatini David M, Salmon Adam B, Simpkins James W, Steegenga Wilma T, Nadon Nancy L and Harrison David E. Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer. : Aging cell. 20170605.